Coronavirus: EMA gives AstraZeneca vaccine renewed backing
Published
The EU's drug regulator has been reviewing AstraZeneca's coronavirus vaccine over concerns about a very rare, but potentially fatal side effect.
Full ArticlePublished
The EU's drug regulator has been reviewing AstraZeneca's coronavirus vaccine over concerns about a very rare, but potentially fatal side effect.
Full ArticleThe AstraZeneca coronavirus vaccine provides a “significant benefit” in avoiding hospital admission across all age groups, the..
BERLIN (AP) — Johnson & Johnson said Tuesday it is delaying the rollout of its coronavirus vaccine in Europe amid a U.S. probe..